Trulieve Cannabis (TRLV) EBIT Margin (2020 - 2026)

Trulieve Cannabis (TRLV) has reported EBIT Margin for 7 consecutive years, with 12.46% the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT Margin rose 127.0% year-over-year to 12.46%; the TTM figure through Mar 2026 stood at 12.47% (up 530.0% YoY), while the FY2025 annual figure was 12.15%, up 391.0% from the prior year.
• EBIT Margin came in at 12.46% for Q1 2026 at Trulieve Cannabis, up from 5.22% in the prior quarter.
• The five-year high for EBIT Margin was 17.42% in Q2 2025, with the low at 103.37% in Q2 2023.
• Average EBIT Margin over 5 years is 1.75%, with a median of 9.18% recorded in 2022.
• Across the five-year window, EBIT Margin sank 11658 bps in 2023 and jumped 11977 bps in 2024, its largest moves.
• Year by year, EBIT Margin stood at 1.74% in 2022, then jumped by 483 bps to 10.17% in 2023, then tumbled by 96 bps to 0.43% in 2024, then surged by 1101 bps to 5.22% in 2025, then surged by 139 bps to 12.46% in 2026.
• According to Business Quant data, EBIT Margin over the past three periods registered 12.46%, 5.22%, and 14.66% for Q1 2026, Q4 2025, and Q3 2025 respectively.